参考文献/References:
[1]Lederer DJ,Martinez FJ.Idiopathic Pulmonary Fibrosis[J].N Engl J Med,2018,378(19):1811-1823.[2]Mori Y,Nishikiori H,Chiba H,et al.Respiratory reactance in forced oscillation technique reflects disease stage and predicts lung physiology deterioration in idiopathic pulmonary fibrosis[J].Respir Physiol Neurobiol,2020(275):103386.[3]Lee SI,Chae EJ,Song JS,et al.Pleuroparenchymal fibroelastosis in patients with idiopathic pulmonary fibrosis[J].Respirology,2020,25(10):1046-1052.[4]Sekihara K,Aokage K,Miyoshi T,et al.Perioperative pirfenidone treatment as prophylaxis against acute exacerbation of idiopathic pulmonary fibrosis: a single-center analysis[J].Surg Today,2020,50(8):905-911.[5]Lynch DA,Sverzellati N,Travis WD,et al.Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper[J].Lancet Respir Med,2018,6(2):138-153.[6]Janssen K,Rosielle D,Wang Q,et al.The impact of palliative care on quality of life,anxiety,and depression in idiopathic pulmonary fibrosis:a randomized controlled pilot study[J].Respir Res,2020,21(1):2.[7]Zhao H,Wang Y,Qiu T,et al.Autophagy,an important therapeutic target for pulmonary fibrosis diseases[J].Clin Chim Acta,2020(502):139-147.[8]Hill C,Li J,Liu D,et al.Autophagy inhibition-mediated epithelial-mesenchymal transition augments local myofibroblast differentiation in pulmonary fibrosis[J].Cell Death Dis,2019,10(8):591.[9]Svoboda P,Krizova E,Sestakova S,et al.Nuclear transport of nicotinamide phosphoribosyltransferase is cell cycle-dependent in mammalian cells,and its inhibition slows cell growth[J].J Biol Chem,2019,294(22):8676-8689.[10]Fan L,Yu X,Huang Z,et al.Analysis of microarray-identified genes and MicroRNAs associated with idiopathic pulmonary fibrosis[J].Mediators Inflamm,2017(2017):1804240.[11]Bauer Y,Tedrow J,de Bernard S,et al.A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis[J].Am J Respir Cell Mol Biol,2015,52(2):217-231.[12]Min F,Gao F,Liu Z.Screening and further analyzing differentially expressed genes in acute idiopathic pulmonary fibrosis with DNA microarray[J].Eur Rev Med Pharmacol Sci,2013,17(20):2784-2790.[13]Raghu G,Remy-Jardin M,Myers JL,et al.Diagnosis of idiopathic pulmonary fibrosis.An official ATS/ERS/JRS/ALAT clinical practice guideline[J].Am J Respir Crit Care Med,2018,198(5):e44-e68.[14]李志杰,杨爽.KL-6、IGFBP-4在特发性肺纤维化患者支气管肺泡灌洗液和血清中的表达及意义[J].临床肺科杂志,2018,23(7):1289-1292.[15]Richards JB.Calculated decisions:mMRC (Modified Medical Research Council) Dyspnea Scale[J].Emerg Med Pract,2017,19(Suppl 10):1-2.[16]Cheng SL,Lin CH,Wang CC,et al.Comparison between COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) dyspnea scores for evaluation of clinical symptoms, comorbidities and medical resources utilization in COPD patients[J].J Formos Med Assoc,2019,118(1 Pt 3):429-435.[17]Kobayashi T,Hataji O,Fujimoto H,et al.Too premature to deny the potential of thrombomodulin alfa in idiopathic pulmonary fibrosis[J].Am J Respir Crit Care Med,2020,201(11):1449-1450.[18]Hochhegger B,Marchiori E,Zanon M,et al.Imaging in idiopathic pulmonary fibrosis:diagnosis and mimics[J].Clinics(Sao Paulo),2019(74):e225.[19]Mancuzo EV,Soares MR,Pereira CAC.Six-minute walk distance and survival time in patients with idiopathic pulmonary fibrosis in Brazil[J].J Bras Pneumol,2018,44(4):267-272.[20]金蕊,苗姝,田惠媛,等.IPF合并肺气肿与未合并肺气肿患者的临床特点、肺功能、影像学及生活质量比较[J].河北医药,2017,39(24):3716-3718.[21]Kalluri M,Luppi F,Ferrara G.What Patients With Idiopathic Pulmonary Fibrosis and Caregivers Want: Filling the Gaps With Patient Reported Outcomes and Experience Measures[J].Am J Med,2020,133(3):281-289.[22]Sosulski ML,Gongora R,Danchuk S,et al.Deregulation of selective autophagy during aging and pulmonary fibrosis:the role of TGFbeta1[J].Aging Cell,2015,14(5):774-783.[23]Romero Y,Bueno M,Ramirez R,et al.mTORC1 activation decreases autophagy in aging and idiopathic pulmonary fibrosis and contributes to apoptosis resistance in IPF fibroblasts[J].Aging Cell,2016,15(6):1103-1112.[24]Maghsoudloo M,Jamalkandi SA,Najafi A,et al.Identification of biomarkers in common chronic lung diseases by co-expression networks and drug-target interactions analysis[J].Mol Med,2020,26(1):9.[25]Muraoka H,Hasegawa K,Sakamaki Y,et al.Role of nampt-sirt6 axis in renal proximal tubules in extracellular matrix deposition in diabetic nephropathy[J].Cell Rep,2019,27(1):199-212.